Home The Chugai group The Chugai group A global presence Chugai Pharma France Chugai's mission and values CHUGAI Ethics Charter Partnership Financial reports Our therapeutic areas Our therapeutic areas Rheumatology Oncology-Hematology Our products Our products RoActemra® (tocilizumab) Granocyte® (lenograstim) R&D R&D Research and development Transparency Transparency Publication of links with health stakeholders Information on link transparency Patients Patients Rheumatology Oncology - Hematology Our products / RoActemra® (tocilizumab) RoActemra® (tocilizumab) Page being updated. Rheumatology Oncology - Hematology Terms of use Legal Notice Sitemap Contact us Last site update: 11/24/2016 - 19:28 This website contains product information which is intended for a wide audience and may contain information or information on various products which is not accessible or valid in your country. We accept no responsibility for access to such information that does not comply with any legal requirements, regulations, registration or use in force in your country of origin.